Pulike Biological Engineering Inc
SSE:603566
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Estee Lauder Companies Inc
NYSE:EL
|
Consumer products
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Church & Dwight Co Inc
NYSE:CHD
|
Consumer products
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
American Express Co
NYSE:AXP
|
Financial Services
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Target Corp
NYSE:TGT
|
Retail
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
|
US |
Mueller Industries Inc
NYSE:MLI
|
Machinery
|
|
US |
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
10.95
24.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches CNY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Estee Lauder Companies Inc
NYSE:EL
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Church & Dwight Co Inc
NYSE:CHD
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
American Express Co
NYSE:AXP
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Target Corp
NYSE:TGT
|
US | |
Walt Disney Co
NYSE:DIS
|
US | |
Mueller Industries Inc
NYSE:MLI
|
US | |
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one Pulike Biological Engineering Inc stock under the Base Case scenario is 21.17 CNY. Compared to the current market price of 13.19 CNY, Pulike Biological Engineering Inc is Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation Backtest
Pulike Biological Engineering Inc
Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Start backtest now and learn if your stock is truly undervalued or overvalued!
Stock is trading at its lowest valuation over the past 5 years.
To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.
The backtest for Pulike Biological Engineering Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Months
Months
Months
Months
Select up to 2 periods:
Revenue & Expenses Breakdown
Pulike Biological Engineering Inc
Balance Sheet Decomposition
Pulike Biological Engineering Inc
Current Assets | 1.2B |
Cash & Short-Term Investments | 508.5m |
Receivables | 468.9m |
Other Current Assets | 213.8m |
Non-Current Assets | 1.9B |
Long-Term Investments | 353.5m |
PP&E | 1.2B |
Intangibles | 293.8m |
Other Non-Current Assets | 38.3m |
Current Liabilities | 441m |
Accounts Payable | 103.9m |
Accrued Liabilities | 37.5m |
Short-Term Debt | 31.8m |
Other Current Liabilities | 267.8m |
Non-Current Liabilities | 36.4m |
Long-Term Debt | 1.1m |
Other Non-Current Liabilities | 35.3m |
Earnings Waterfall
Pulike Biological Engineering Inc
Revenue
|
1.1B
CNY
|
Cost of Revenue
|
-446.8m
CNY
|
Gross Profit
|
674.4m
CNY
|
Operating Expenses
|
-550.5m
CNY
|
Operating Income
|
124m
CNY
|
Other Expenses
|
7m
CNY
|
Net Income
|
131m
CNY
|
Free Cash Flow Analysis
Pulike Biological Engineering Inc
CNY | |
Free Cash Flow | CNY |
Profitability Score
Profitability Due Diligence
Pulike Biological Engineering Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Score
Pulike Biological Engineering Inc's profitability score is 49/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Pulike Biological Engineering Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Score
Pulike Biological Engineering Inc's solvency score is 84/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Pulike Biological Engineering Inc
According to Wall Street analysts, the average 1-year price target for Pulike Biological Engineering Inc is 14.94 CNY with a low forecast of 13.84 CNY and a high forecast of 16.01 CNY.
Dividends
Current shareholder yield for Pulike Biological Engineering Inc is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Profile
Country
Industry
Market Cap
Dividend Yield
Description
Pulike Biological Engineering, Inc. engages in the research, development, manufacturing and sale of biological products for animals, chemical drugs and Chinese veterinary drugs. The company is headquartered in Luoyang, Henan and currently employs 1,809 full-time employees. The company went IPO on 2015-05-18. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The firm's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
Contact
IPO
Employees
Officers
The intrinsic value of one Pulike Biological Engineering Inc stock under the Base Case scenario is 21.17 CNY.
Compared to the current market price of 13.19 CNY, Pulike Biological Engineering Inc is Undervalued by 38%.